Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Optic neuritis combined with hepatitis B and neurosyphilis.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.
In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study.
Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR.
Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis.
Treatment of Neuromyelitis Optica: Review and Recommendations.
Fiber density index in the evaluation of the spinal cord in patients with multiple sclerosis.
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Spinal Cord Normalization in Multiple Sclerosis.
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study.
Multiple sclerosis: individualized disease susceptibility and therapy response.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
[Natalizumap can induce progressive multifocal leucoencephalopathy.]
The risk of developing depression when suffering from neurological diseases.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity.
Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy.
Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.

Pages